Clinical Trial Update: Retrospective Study Collecting Neurological Follow-up of Hereditary Transthyretin Amyloidosis (ATTRv) Patients Included in B3461028 and B3461045.

View source ↗

Summary

This is a completed retrospective study collecting neurological follow-up data from hereditary transthyretin amyloidosis (ATTRv) patients enrolled in trials B34…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hereditary Transthyretin Amyloidosis
• Polyneuropathy

Snippet

Sponsor: Pfizer | Conditions: Hereditary Transthyretin Amyloidosis (ATTRv), Polyneuropathy | Status: COMPLETED | Results posted: 2024-05-13